Evangelidis P, Tragiannidis K, Gavriilaki E, Tragiannidis A
Curr Issues Mol Biol. 2025; 47(1).
PMID: 39852180
PMC: 11763769.
DOI: 10.3390/cimb47010065.
Liu Y, Zuo X, Chen P, Hu X, Sheng Z, Liu A
Signal Transduct Target Ther. 2022; 7(1):347.
PMID: 36202780
PMC: 9537316.
DOI: 10.1038/s41392-022-01167-9.
Kim D, Shin D, Liu J, Jeong N, Koh Y, Hong J
Stem Cell Rev Rep. 2022; 18(8):2982-2994.
PMID: 35687264
DOI: 10.1007/s12015-022-10386-0.
Bussel J, Soff G, Balduzzi A, Cooper N, Lawrence T, Semple J
Drug Des Devel Ther. 2021; 15:2243-2268.
PMID: 34079225
PMC: 8165097.
DOI: 10.2147/DDDT.S299591.
Ichimata S, Kobayashi M, Honda K, Shibata S, Matsumoto A, Kanno H
World J Gastroenterol. 2017; 23(35):6540-6545.
PMID: 29085203
PMC: 5643279.
DOI: 10.3748/wjg.v23.i35.6540.
Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.
Perdomo J
Immunotargets Ther. 2016; 5:1-7.
PMID: 27529057
PMC: 4970631.
DOI: 10.2147/ITT.S80648.
Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M, Perdomo J, Yan F, Choi P, Chong B
Haematologica. 2015; 100(5):623-32.
PMID: 25682608
PMC: 4420211.
DOI: 10.3324/haematol.2014.115634.
Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.
Cheng G
Ther Adv Hematol. 2013; 3(3):155-64.
PMID: 23556122
PMC: 3573439.
DOI: 10.1177/2040620712442525.
Platelet Kinetics in Idiopathic Thrombocytopenic Purpura Patients Treated with Thrombopoietin Receptor Agonists.
Meyer O, Herzig E, Salama A
Transfus Med Hemother. 2012; 39(1):5-8.
PMID: 22896760
PMC: 3388617.
DOI: 10.1159/000335553.
Treatment of immune thrombocytopenic purpura: focus on eltrombopag.
Rice L
Biologics. 2009; 3:151-7.
PMID: 19707404
PMC: 2726065.
DOI: 10.2147/btt.2009.2984.
Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura.
Stasi R, Evangelista M, Amadori S
Drugs. 2008; 68(7):901-12.
PMID: 18457458
DOI: 10.2165/00003495-200868070-00002.
Antigenic differences between human platelets and megakaryocytes.
Hyde P, Zucker-Franklin D
Am J Pathol. 1987; 127(2):349-57.
PMID: 3555103
PMC: 1899752.
Human megakaryocytic progenitor cells.
Kanz L, LOHR G, Fauser A
Klin Wochenschr. 1987; 65(7):297-307.
PMID: 2438450
DOI: 10.1007/BF01745383.
